The reduction of our net loss in 2025 from 2024 was primarily related to the LifeSci Capital LLC judgment expense and reimbursement of legal costs, clinical trial related settlement expenses with A-IR ...
Eleven clinical trial sites in BASECAMP currently active; remaining planned sites to be activated throughout Q2 2026BASECAMP remains on track to complete enrollment in Q3 2026The Company has initiated ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 7:35 PM EDTCompany ParticipantsPaul LaViolette - ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
1d
Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study
Inhibrx Biosciences, Inc. (NASDAQ:INBX) is one of the best small cap stocks to buy for 10x potential. Inhibrx Biosciences, ...
Market forces rained on the parade of Assembly Biosciences, Inc. (NASDAQ:ASMB) shareholders today, when the analysts downgraded their forecasts for this year. Both revenue and ear ...
View Aura Biosciences Inc AURA stock quote prices, financial information, real-time forecasts, and company news from CNN.
View Sagimet Biosciences Inc. Class A SGMT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results